Christer Borgfeldt
41 – 50 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients – a comparative cohort study
(
- Contribution to journal › Article
-
Mark
Prevalence of high-risk HPV in postmenopausal women with benign cervical cytology - A population-based cohort study
(
- Contribution to journal › Article
- 2017
-
Mark
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
(
- Contribution to journal › Article
-
Mark
Vaginal and urine self-sampling compared to cervical sampling for HPV-testing with the cobas 4800 HPV test
(
- Contribution to journal › Article
-
Mark
Postmenopausal hormone therapy and risk of stroke : A pooled analysis of data from population-based cohort studies
(
- Contribution to journal › Article
-
Mark
Risk factors for lymph node metastases in women with endometrial cancer : A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group
(
- Contribution to journal › Article
-
Mark
The economic burden of human papillomavirus-related precancers and cancers in Sweden
(
- Contribution to journal › Article
-
Mark
Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women : the Malmö Diet and Cancer Study
(
- Contribution to journal › Article